We analyzed deidentified data from an EHR-derived database for patients with advanced non–small cell lung cancer (aNSCLC) at their first line of treatment. Our novel imputation method involved (1) ...
Incorporating ICIs into platinum-doublet regimens improved OS and ORR in ES-SCLC patients with ECOG PS 2 to 3, but not in those with ECOG PS 0 to 1. The study found manageable adverse reactions, with ...
Eastern Cooperative Oncology Group performance status (ECOG PS) is a key confounder in comparative effectiveness research, predicting treatment and survival, but is often incomplete in electronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback